About Gerresheimer
Gerresheimer is a publicly listed company based in Dusseldorf (Germany) founded in 1864 by Ferdinand Heye, and was acquired by Blackstone in November 2014. Primary packaging for medication and drug delivery devices is manufactured. The company has 12,140 employees. Gerresheimer has completed 4 acquisitions, including Blitzluxco, Bormioli Pharma and Sensile Medical. Its chief executive, as recorded, is Dietmar Siemssen. Its website gerresheimer.com draws about 36 thousand monthly visits. Gerresheimer offers products and services including Primary Packaging and Drug Delivery Systems. Its focus areas include Medical Supplies and Consumables and Packaging. Its legal entity is Gerresheimer AG.
Company details
Gerresheimer was founded in 1864 in Dusseldorf, Germany, by Ferdinand Heye. Operations focus on the pharmaceutical, health, well-being, and biotech sectors. Glass and plastic packaging solutions are produced for drug delivery systems. Prefillable syringes and cartridges made of glass or plastic are offered as key products. The company serves global markets from its base in Germany.
- Headquarters Dusseldorf, Germany
- Employees 12,140
- Founders Ferdinand Heye
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gerresheimer.com
- Social LinkedIn X Facebook YouTube
- Acquired by Blackstone (Nov 2014)
- Legal Name Gerresheimer Ag
- Annual Revenue$2.68 B (USD)16.55as on Nov 30, 2025
- Net Profit-$370.48 M (USD)-489.32as on Nov 30, 2025
- EBITDA$435.58 M (USD)5.27as on Nov 30, 2025
- Latest Funding Round$603.85M (USD), Debt – Conventional
Oct 2019
- Investors
- Employee Count12,140
- Investments & AcquisitionsBlitzluxco
& 3 more
- Acquired byBlackstone
(Nov 2014)
Products & Services of Gerresheimer
Gerresheimer offers a comprehensive portfolio of products and services, including Primary Packaging and Drug Delivery Systems.
High-quality glass and plastic packaging solutions are developed for pharmaceuticals and are utilized in various formulations.
Integrated solutions are provided from concept development to finished products for drug delivery, encompassing injectors and inhalers.
Apps and channels of Gerresheimer
its YouTube channel Gerresheimer has 544 subscribers and 9 videos.
Videos from Gerresheimer
The most watched videos on Gerresheimer's YouTube channel, Gerresheimer (544 subscribers). Click a video to play it here.
More on Gerresheimer.
Funding Insights of Gerresheimer
- Total Rounds 2
- Last Round Debt – Conventional — $603.85M
- First Round $457.15M
(Nov 2015)
All 2 funding rounds of Gerresheimer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $603.85M | Debt – Conventional | – | – | – |
| Nov 2015 | $457.15M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Gerresheimer
Gerresheimer has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Blackstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States |
Investor details for Gerresheimer
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gerresheimer
3 people are tracked at Gerresheimer (2 in leadership, 1 in team); the tracked headcount is 12,140.
| Name | Role | Group |
|---|---|---|
Ferdinand Heye | Founder | Leadership |
Dietmar Siemssen | CEO | Leadership |
Axel Herberg | Chairman Of The Supervisory Board | Team |
Complete people profiles for Gerresheimer
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Gerresheimer
Gerresheimer is a publicly listed company on the XETR with ticker symbol GXI in Germany, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jun 2007
- Listed onFRA: GXI
- Listed entityGerresheimer AG
- Exchange sectorProcess industries
- ISINDE000A0LD6E6
- Share price29.40 EUR (+1.17% on the day) · 2026-10-14
- Market capitalisation1,003,732,408.00 EUR
- Price to earnings39.5
- EPS (diluted, trailing year)-11.60 EUR
- Dividend yield0.14%
- Volume (last session)30,664
Financials of Gerresheimer
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.32B EUR | -320.3M EUR | 376.6M EUR |
| 2024 | 1.99B EUR | 82.3M EUR | 357.7M EUR |
| 2023 | 1.99B EUR | 116.1M EUR | 396.3M EUR |
| 2022 | 1.82B EUR | 96.1M EUR | 350.5M EUR |
| 2021 | 1.50B EUR | 83.8M EUR | 291.5M EUR |
Detailed financial statements for Gerresheimer
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gerresheimer
Gerresheimer has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Blitzluxco, Bormioli Pharma and Sensile Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical packaging products are manufactured and supplied globally. | bormiolipharma.com | Parma, Italy | 1825 | May 2024 | $867.23M | |
| blitzluxco.tcc.mode | 0 | May 2024 | •••• | |||
Drug Delivery Solutions | sensile-medical.com | Zurich, Switzerland | 2004 | Jul 2018 | $409.86M | |
Manufacturer of technical plastics molding products | wilden.com | Grand Terrace, United States | 1955 | Jan 2007 | •••• |
Complete acquisition details for Gerresheimer
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Gerresheimer
9 dated milestones of Gerresheimer across 160 years, from founding to its latest funding, stage changes and deals.
- Founded Gerresheimer is founded.
- Acquisition Acquires Wilden.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Blackstone.
- Funding First funding round of $457.1M.
- Acquisition Acquires Sensile Medical.
- Funding Latest funding round, Debt – Conventional, of $603.8M.
- Acquisition Acquires Blitzluxco.
- Acquisition Acquires Bormioli Pharma.
Web traffic of Gerresheimer
The website of Gerresheimer (gerresheimer.com) receives about 35.5K visits a month.
- Monthly visits35.5K
▲ 4.2% vs previous month
Websites whose visitors overlap most with Gerresheimer. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ocme.com | 100% | 7.4K | #2,662,169 | View details | |
| heinz-glas.com | 92% | 5.6K | #3,247,283 | View details | |
| ardaghgroup.com | 91% | 79.9K | #406,231 | View details | |
| sonoco.com | 87% | 141.3K | #283,851 | View details | |
packaging-gateway.com | packaging-gateway.com | 85% | #478,671 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Gerresheimer
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gerresheimer
Complete news archive for Gerresheimer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gerresheimer
Gerresheimer was founded in 1864 and raised its 1st funding round 151 years after it was founded.
Gerresheimer is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Dietmar Siemssen is the CEO of Gerresheimer, as recorded in our data.
Gerresheimer has 12,140 employees.
Annual revenue of Gerresheimer is $2.68B as on Nov 30, 2025.
Gerresheimer was founded in 1864 in Dusseldorf, Germany, by Ferdinand Heye. Operations focus on the pharmaceutical, health, well-being, and biotech sectors. Glass and plastic packaging solutions are produced for drug delivery systems. Prefillable syringes and cartridges made of glass or plastic are offered as key products. The company serves global markets from its base in Germany.
Gerresheimer offers Primary Packaging and Drug Delivery Systems.
Yes, Gerresheimer is publicly traded on XETR under the ticker symbol GXI.
Gerresheimer has made 4 acquisitions, including Blitzluxco, Bormioli Pharma, and Sensile Medical.
Gerresheimer has 1 investor. Key investors include Blackstone.
Gerresheimer operates through Gerresheimer Ag.
Yes. Gerresheimer was acquired by Blackstone in November 2014.